Sanofi takes a bold step by acquiring Blueprint MedicinesSanofi Makes Bold Move with $9.5 Billion Acquisition of Blueprint Medicines
By Ion Jauregui – Analyst at ActivTrades
French pharmaceutical giant Sanofi (EPA:SAN) has kicked off 2025 with a bold strategic move: the acquisition of U.S.-based biotech Blueprint Medicines (NASDAQ:BPMC) for up to $9.5 b
7.39 EUR
5.56 B EUR
41.08 B EUR
1.11 B
About Sanofi SA
Sector
Industry
CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
FR0000120578
FIGI
BBG000F5DZZ1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
Related stocks
Short on SANOFI (SAN)Short until 87.0 (support zone).
Strong selling pressure confirmed by two large red candles.
Recent green candle shows buyer hesitation (small body, upper wick).
No significant volume to support a bullish rebound.
RSI remains weak but needs surveillance.
Rebound lacking conviction.
Sanofi (SNY): A Strong Investment CaseCompany Overview:
Sanofi NASDAQ:SNY is a major pharmaceutical company based in Paris, with a market capitalization of $134 billion.
Investment Highlights:
Dividend Yield: 3.8%, more than double the S&P 500 average.
Drug Portfolio: Diverse and includes successful drug developments.
Pipeline: Prom
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
Sanofi SA 3.625% 19-JUN-2028Yield to maturity
3.91%
Maturity date
Jun 19, 2028
FR1332437
Sanofi SA 1.875% 21-MAR-2038Yield to maturity
3.57%
Maturity date
Mar 21, 2038
FR1340985
Sanofi 1.25% 21-MAR-2034Yield to maturity
3.27%
Maturity date
Mar 21, 2034
FR14010MR
Sanofi SA 3.0% 23-JUN-2032Yield to maturity
3.10%
Maturity date
Jun 23, 2032
FR1400Y1I
Sanofi SA 2.75% 11-MAR-2031Yield to maturity
2.93%
Maturity date
Mar 11, 2031
FR1332435
Sanofi SA 1.375% 21-MAR-2030Yield to maturity
2.81%
Maturity date
Mar 21, 2030
FR1350511
Sanofi 1.5% 01-APR-2030Yield to maturity
2.79%
Maturity date
Apr 1, 2030
A1Z6Y6
Sanofi 1.5% 22-SEP-2025 2015-22.9.25Yield to maturity
2.69%
Maturity date
Sep 22, 2025
FR1340984
Sanofi 0.875% 21-MAR-2029Yield to maturity
2.67%
Maturity date
Mar 21, 2029
FR14010MQ
Sanofi SA 2.625% 23-JUN-2029Yield to maturity
2.62%
Maturity date
Jun 23, 2029
FR1314400
Sanofi 1.125% 05-APR-2028Yield to maturity
2.40%
Maturity date
Apr 5, 2028
See all 1SAN bonds
Curated watchlists where 1SAN is featured.
Frequently Asked Questions
The current price of 1SAN is 80.64 EUR — it has increased by 0.64% in the past 24 hours. Watch Sanofi SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Sanofi SA stocks are traded under the ticker 1SAN.
1SAN stock has fallen by −0.42% compared to the previous week, the month change is a −6.76% fall, over the last year Sanofi SA has showed a −22.55% decrease.
We've gathered analysts' opinions on Sanofi SA future price: according to them, 1SAN price has a max estimate of 124.80 EUR and a min estimate of 78.00 EUR. Watch 1SAN chart and read a more detailed Sanofi SA stock forecast: see what analysts think of Sanofi SA and suggest that you do with its stocks.
1SAN reached its all-time high on Mar 24, 2025 with the price of 111.00 EUR, and its all-time low was 37.70 EUR and was reached on Oct 10, 2008. View more price dynamics on 1SAN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1SAN stock is 1.87% volatile and has beta coefficient of 0.85. Track Sanofi SA stock price on the chart and check out the list of the most volatile stocks — is Sanofi SA there?
Today Sanofi SA has the market capitalization of 97.90 B, it has decreased by −1.61% over the last week.
Yes, you can track Sanofi SA financials in yearly and quarterly reports right on TradingView.
1SAN net income for the last half-year is 5.81 B EUR, while the previous report showed 3.31 B EUR of net income which accounts for 75.38% change. Track more Sanofi SA financial stats to get the full picture.
Yes, 1SAN dividends are paid annually. The last dividend per share was 3.92 EUR. As of today, Dividend Yield (TTM)% is 4.87%. Tracking Sanofi SA dividends might help you take more informed decisions.
Sanofi SA dividend yield was 4.18% in 2024, and payout ratio reached 88.23%. The year before the numbers were 4.19% and 87.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 21, 2025, the company has 84.59 K employees. See our rating of the largest employees — is Sanofi SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanofi SA EBITDA is 13.86 B EUR, and current EBITDA margin is 31.98%. See more stats in Sanofi SA financial statements.
Like other stocks, 1SAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanofi SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanofi SA stock shows the sell signal. See more of Sanofi SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.